BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11417750)

  • 1. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis.
    Marenzi G; Lauri G; Guazzi M; Assanelli E; Grazi M; Famoso G; Agostoni P
    Am J Med Sci; 2001 Jun; 321(6):359-66. PubMed ID: 11417750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular circulatory adjustments and renal function in acute heart failure.
    Seino Y; Shimai S; Tanaka K; Takano T; Hayakawa H
    Jpn Circ J; 1989 Feb; 53(2):180-90. PubMed ID: 2654439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
    Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
    Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure.
    Cody RJ; Torre S; Clark M; Pondolfino K
    Arch Intern Med; 1989 May; 149(5):1023-8. PubMed ID: 2655542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention.
    Guazzi MD; Agostoni P; Perego B; Lauri G; Salvioni A; Giraldi F; Matturri M; Guazzi M; Marenzi G
    Br Heart J; 1994 Dec; 72(6):534-9. PubMed ID: 7857735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
    Rouleau JL; Packer M; Moyé L; de Champlain J; Bichet D; Klein M; Rouleau JR; Sussex B; Arnold JM; Sestier F
    J Am Coll Cardiol; 1994 Sep; 24(3):583-91. PubMed ID: 7915733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function.
    Ljungman S; Laragh JH; Cody RJ
    Drugs; 1990; 39 Suppl 4():10-21; discussion 22-4. PubMed ID: 2354670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
    Hillege HL; Girbes AR; de Kam PJ; Boomsma F; de Zeeuw D; Charlesworth A; Hampton JR; van Veldhuisen DJ
    Circulation; 2000 Jul; 102(2):203-10. PubMed ID: 10889132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neurohumoral systems during the development of congestive heart failure: impact on cardiovascular and renal function.
    Elsner D
    Eur Heart J; 1995 Dec; 16 Suppl N():52-8. PubMed ID: 8682062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction.
    Vaughan DE; Lamas GA; Pfeffer MA
    Am J Cardiol; 1990 Sep; 66(5):529-32. PubMed ID: 1975472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators.
    Benedict CR; Johnstone DE; Weiner DH; Bourassa MG; Bittner V; Kay R; Kirlin P; Greenberg B; Kohn RM; Nicklas JM
    J Am Coll Cardiol; 1994 May; 23(6):1410-20. PubMed ID: 7909822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
    Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
    Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
    Schofer J; Hobuss M; Aschenberg W; Tews A
    Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up.
    Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of the neurohumoral axis after intravascular fluid depletion in congestive heart failure with water retention: mechanisms of the perpetuation of the syndrome].
    Marenzi G; Lauri G; Guazzi M; Perego GB; Matturri M; Salvioni A; Giraldi F; Agostoni PG
    Cardiologia; 1995 Jan; 40(1):15-22. PubMed ID: 8529234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interrelation of plasma volume, fluid metabolism and neurohormonal activation after ultrafiltration in congestive heart failure].
    Marenzi G; Agostoni PG; Lauri G; Perego GB; Grazi M; Schianni M; Giraldi F; Salvioni A; Guazzi M
    Cardiologia; 1992 Dec; 37(12):831-7. PubMed ID: 1363883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.